InnovaGyn, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Ovulation in Obese Women (NCT06306131) | InnovaGyn, Inc. | 2023-12-10 |
| Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days (NCT05695352) | InnovaGyn, Inc. | 2022-06-28 |
Track InnovaGyn, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.